Quetiapine: a review of its safety in the management of schizophrenia.

  title={Quetiapine: a review of its safety in the management of schizophrenia.},
  author={Vishva Dev and J. Raniwalla},
  journal={Drug safety},
  volume={23 4},
Quetiapine, a dibenzothiazepine derivative, is a atypical antipsychotic which has greater in vitro binding affinity for serotonin 5-HT2 receptors than for dopamine D2 receptors. Quetiapine effectively treats both the positive and the negative symptoms of schizophrenia and is also associated with an incidence of extrapyramidal symptoms no greater than placebo across the entire dose range. In addition, it does not cause persistent hyperprolactinaemia. Quetiapine is associated with high levels of… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…